Skip to main content
. 2022 Feb 15;49(3):381–394. doi: 10.1007/s10928-021-09799-0

Table 6.

Terminal half-life, steady-state and accumulation ratio for each entity (after 100 mg/m2 Q2W dosing)

Entity Terminal half-life (days) Steady-state Racc for AUCTAU Racc for Cmax
SAR408701 8.8 Cycle 3 1.4 1.3
DM4 8.7a Cycle 3 1.1 1.1
MeDM4 8.7a Cycle 3 1.3 1.3
NAB 12.2 Cycle 6 2.9 2.5

aApparent terminal half-life: formation limited kinetic for DM4 and MeDM4